The data about the structure and the mechanisms of participation of p53 protein in regulation of the cell cycle checkpoints, DNA repair and apoptosis in normal conditions and after ionizing irradiation are considered. The double strand break of DNA, as a signal of radiation damage, lead to binding of ATM protein with DNA, to appearance of the protein kinase activity at the ATM protein, that after phosphorylation of p53 protein lead to its stabilization and activation. It is noted, that the p53 protein is an integrator of environmental lesion signals, which triggers the transcription, that activate or inhibite the synthesis of protein factors leading to cell cycle arrest in the checkpoints, to increase of DNA repair or to apoptosis. The data evidenced the participation of p53 protein in radioresistance formation are considered: p53 protein after mutation changes loses the control over the cell cycle, DNA repair and apoptosis, and that leads both to the radioresistance increase and to the possibility of the radiation-induced defects retention in progeny of the irradiated cells and organisms. Potential prospective research directions in radiobiology in connection with the data on the molecular biology of p53 gene and protein (the problems of norm, radiosensitivity/radioresistance, drug research for prophylaxe and treatment of radiation injury, low dose effect including by high density irradiation) are reviewed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

p53 protein
20
cell cycle
12
dna repair
12
repair apoptosis
12
protein
10
participation p53
8
atm protein
8
p53
7
dna
5
[problems radiobiology
4

Similar Publications

IP6K1 rewires LKB1 signaling to mediate hyperglycemic endothelial senescence.

Diabetes

January 2025

Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

Diabetes is a major risk factor for cardiovascular disease, but the molecular mechanisms underlying diabetic vasculopathy have been elusive. Here we report that inositol hexakisphosphate kinase 1 (IP6K1) mediates hyperglycemia-induced endothelial senescence by rewiring the liver kinase B1 (LKB1) signaling from activating the adenosine monophosphate-activated protein kinase (AMPK) pathway to the p53 pathway. We found that hyperglycemia upregulated IP6K1, which disrupts the Hsp/Hsc70 and carboxyl terminus of Hsc70-interacting protein (CHIP)-mediated LKB1 degradation, leading to increased expression levels of LKB1.

View Article and Find Full Text PDF

Purpose: Developmentally regulated GTP-binding protein 2 (DRG2) regulates microtubule dynamics and G2/M arrest during docetaxel treatment. Poly ADP-ribose polymerase (PARP) acts as an important repair system for DNA damage caused by docetaxel treatment. This study investigated whether DRG2 expression affects response to PARP inhibitors (olaparib) using prostate cancer cell lines PC3, DU145, LNCaP-FGC, and LNCaP-LN3.

View Article and Find Full Text PDF

Ovarian cancer (OC) is a significant cause of cancer-related mortality among women. This study explores the efficacy of L. () extract, known for its phytoestrogenic properties, in treating OC through hormonal and metabolic modulation.

View Article and Find Full Text PDF

Nuclear factor erythroid 2-related factor 2 (NRF2), a transcription factor regulating cellular redox homeostasis, exhibits a complex role in cancer biology. Genetic mutations in the Kelch-like ECH-associated protein 1 (KEAP1)/NRF2 system, which lead to NRF2 hyperactivation, are found in 20% to 30% of lung cancer cases. This review explores the intricate interplay between NRF2 and key oncogenic pathways in lung cancer, focusing on the interaction of KEAP1/NRF2 system with Kirsten rat sarcoma virus (KRAS), tumor protein P53 (TP53), epidermal growth factor receptor (EGFR), and phosphatidylinositol 3-kinases (PI3K)/AKT signaling.

View Article and Find Full Text PDF

Objectives: To construct a prediction model based on deep learning (DL) and radiomics features of diffusion weighted imaging (DWI), and clinical variables for evaluating TP53 mutations in endometrial cancer (EC).

Methods: DWI and clinical data from 155 EC patients were included in this study, consisting of 80 in the training set, 35 in the test set, and 40 in the external validation set. Radiomics features, convolutional neural network-based DL features, and clinical variables were analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!